Today we published our first report on Adamis Pharmaceuticals Corp. (ADMP-OTCBB), an innovative biopharmaceutical company combining specialty pharmaceuticals and biotechnology to create treatment options for the following:
Posted by Laura Swartz
October 25, 2011 at 8:44 AM
Today we published our first report on Adamis Pharmaceuticals Corp. (ADMP-OTCBB), an innovative biopharmaceutical company combining specialty pharmaceuticals and biotechnology to create treatment options for the following:
Topics: New Research
We provide investor-based research and corporate communications services to companies worldwide. Visit our About Us page to learn more.
CONTACT INFORMATION
Phone: (212) 851-6685